[1]
W. Saleem, “Single Center Study: Using Pre-Treatment Neutrophil to Lymphocyte Ratio as a Predictor of Outcome in Metastatic Breast Cancer Patients Treated with Cyclin Dependent Kinase 4/6 Inhibitors”, IJBR, vol. 3, no. 7, pp. 344–350, Jul. 2025, doi: 10.70749/ijbr.v3i7.1877.